Stockscreener 앱 받기
107.11
5.70%
-6.6349
전일 마감가:
$113.74
열려 있는:
$102.46
하루 거래량:
672.95K
Relative Volume:
1.12
시가총액:
$7.11B
수익:
$136.86M
순이익/손실:
$-168.69M
주가수익비율:
-38.12
EPS:
-2.81
순현금흐름:
$-113.49M
1주 성능:
-5.46%
1개월 성능:
+8.32%
6개월 성능:
+67.57%
1년 성능:
+102.42%
1일 변동 폭
$102.10
$112.66
1주일 범위
$102.10
$116.00
52주 변동 폭
$45.91
$116.00
Rhythm Pharmaceuticals Inc Stock (RYTM) Company Profile
명칭
Rhythm Pharmaceuticals Inc
전화
857-264-4280
주소
222 BERKELEY STREET, BOSTON, MA
RYTM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
RYTM
Rhythm Pharmaceuticals Inc
|
107.06 | 7.55B | 136.86M | -168.69M | -113.49M | -2.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.60 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.82 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.38 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Rhythm Pharmaceuticals Inc Stock (RYTM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 개시 | Goldman | Buy |
| 2025-07-07 | 개시 | Leerink Partners | Outperform |
| 2025-04-07 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-03-05 | 재개 | Stifel | Buy |
| 2025-01-02 | 개시 | Jefferies | Buy |
| 2024-12-20 | 개시 | Oppenheimer | Outperform |
| 2024-10-21 | 개시 | Guggenheim | Buy |
| 2024-09-18 | 개시 | H.C. Wainwright | Buy |
| 2024-09-17 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-08 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2023-12-19 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-08-01 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-01-18 | 재개 | Canaccord Genuity | Buy |
| 2022-08-08 | 업그레이드 | Goldman | Neutral → Buy |
| 2022-08-05 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-06-17 | 재확인 | Needham | Buy |
| 2022-03-02 | 재개 | Stifel | Buy |
| 2022-02-17 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2021-12-08 | 개시 | Wells Fargo | Overweight |
| 2021-11-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2021-09-14 | 재개 | Goldman | Neutral |
| 2021-08-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-08-04 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-30 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-01-08 | 개시 | Goldman | Sell |
| 2019-07-12 | 업그레이드 | Stifel | Hold → Buy |
| 2019-07-08 | 개시 | Canaccord Genuity | Buy |
| 2019-03-13 | 개시 | Ladenburg Thalmann | Buy |
| 2018-09-07 | 재개 | Morgan Stanley | Overweight |
| 2018-06-25 | 재확인 | Needham | Buy |
| 2018-06-15 | 재확인 | Needham | Buy |
| 2017-10-30 | 개시 | BofA/Merrill | Buy |
| 2017-10-30 | 개시 | Needham | Buy |
모두보기
Rhythm Pharmaceuticals Inc 주식(RYTM)의 최신 뉴스
Needham Raises Price Target for RYTM to $122, Maintains Buy Rati - GuruFocus
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q3 Loss, Tops Revenue Estimates - Yahoo! Finance UK
Rhythm Pharmaceuticals’ Revenue Leaps On Rare Disease Drug Sales - Finimize
Rhythm Pharmaceuticals (RYTM) Exceeds Q3 Revenue Expectations - GuruFocus
Rhythm Pharmaceuticals Q3 2025 Earnings: Revenue Surpasses Estimates at $51.3M, EPS Misses with $0.82 Loss - GuruFocus
Earnings Flash (RYTM) Rhythm Pharmaceuticals, Inc. Reports Q3 Revenue $51.3M, vs. FactSet Est of $50.7M - MarketScreener
Rhythm Pharmaceuticals, Inc. Q3 Loss Increases, Misses Estimates - Nasdaq
Rhythm Pharma Q3 product revenue up 54% yr/yr on IMCIVREE sales - MarketScreener
Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update - TradingView
Why retail investors favor Rhythm Pharmaceuticals Inc. stockJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - newser.com
[8-K] RHYTHM PHARMACEUTICALS, INC. Reports Material Event | RYTM SEC FilingForm 8-K - Stock Titan
Rhythm Pharma (NASDAQ: RYTM) Granted FDA Priority Review; PDUFA Dec. 20, 2025 - Stock Titan
Rhythm Pharmaceuticals Q3 2025 Earnings Preview - MSN
Is it time to cut losses on Rhythm Pharmaceuticals Inc.Market Trend Review & Community Shared Stock Ideas - newser.com
What to do if you’re stuck in Rhythm Pharmaceuticals Inc.Watch List & Verified Short-Term Plans - newser.com
Will Rhythm Pharmaceuticals Inc. price bounce be sustainableWeekly Earnings Recap & Low Volatility Stock Suggestions - newser.com
Can Rhythm Pharmaceuticals Inc. stock weather global recessionWeekly Stock Summary & Daily Volume Surge Signals - newser.com
Rhythm Pharmaceuticals, Inc. (RYTM) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
[Form 4] RHYTHM PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Will Rhythm Pharmaceuticals Inc. stock benefit from automationQuarterly Trade Summary & High Win Rate Trade Tips - newser.com
Visualizing Rhythm Pharmaceuticals Inc. stock with heatmapsWeekly Profit Report & Expert Approved Trade Ideas - newser.com
How resilient is Rhythm Pharmaceuticals Inc. stock in market downturnsWeekly Trade Review & Free Fast Entry Momentum Trade Alerts - newser.com
Is Rhythm Pharmaceuticals Inc. (1RV) stock supported by free cash flowJuly 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Can machine learning forecast Rhythm Pharmaceuticals Inc. recoveryLong Setup & Weekly Top Performers Watchlists - newser.com
Can Rhythm Pharmaceuticals Inc. (1RV) stock hold up in economic slowdownCPI Data & Weekly Return Optimization Plans - newser.com
Is Rhythm Pharmaceuticals Inc. stock positioned for digital transformationWeekly Gains Summary & Step-by-Step Swing Trade Plans - newser.com
Is a relief rally coming for Rhythm Pharmaceuticals Inc. holdersJuly 2025 Institutional & Consistent Profit Alerts - newser.com
How currency fluctuations impact Rhythm Pharmaceuticals Inc. stockWeekly Risk Summary & Safe Capital Growth Stock Tips - newser.com
Published on: 2025-11-02 22:26:41 - newser.com
Is Rhythm Pharmaceuticals Inc. reversing from oversold territoryLayoff News & Free Long-Term Investment Growth Plans - newser.com
Rhythm Pharmaceuticals Hits New 52-Week High of $116.00 - Markets Mojo
Rhythm Pharmaceuticals, Inc. $RYTM Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells $323,753.15 in Stock - MarketBeat
Rhythm Pharmaceuticals Inc (RYTM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.84%
자본화:
|
볼륨(24시간):